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ATTITUDES OF CLINICIANS TOWARDS CARDIAC SURGERY AND TRISOMY 18 
 Meagan E. Kaulfus, B.S. 
Advisory Professor: Rebecca Carter, M.S. 
 
ABSTRACT 
Trisomy 18 is an autosomal trisomy characterized by minor to major birth defects, 
severe disabilities, and high rates of pre- and neonatal mortality. Interventions for these 
infants have traditionally been withheld with focus instead on palliative support. The 
issues and attitudes surrounding surgical treatment of congenital heart defects, which 
occur in approximately 90% of infants with trisomy 18, is of our study’s interest as recent 
literature has indicated that cardiac surgery is being performed and may lead to improved 
survival compared to palliative care. In this study, the attitudes of clinicians of multiple 
specialties towards cardiac surgery for infants with trisomy 18 was evaluated along with 
approaches used by cardiac surgeons to determine candidates for surgery. Of the 378 
participants, 48% felt it was appropriate to discuss the option of cardiac surgery. Ethical 
considerations and insufficient outcome data were the most agreed upon reasons for not 
offering cardiac surgery in majority of clinicians. Overall, prenatal physicians were more 
likely to disagree with offering cardiac surgery than postnatal physicians and genetic 
counselors. Trisomy 18 not being uniformly lethal was the most agreed upon justification 
among clinicians in support of offering surgery, followed by respect for expression of 
parental wishes. Cardiac surgeons were more likely to perform surgery on less complex 
heart defects in the absence of additional anomalies or presence of less severe anomalies.  
Results from this study do not seek to suggest uniform care for these infants, but aim to 
promote discussion and collaboration among clinicians to improve patient care. 
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INTRODUCTION 
Trisomy 18, or Edwards syndrome, is an autosomal trisomy involving an extra copy of 
chromosome 18. Following Down syndrome, trisomy 18 is the second most common autosomal 
trisomy with a quoted prevalence of 1 in 3,000 to 1 in 8,000 live births. Children with trisomy 
18 have minor to major birth defects, severe psychomotor and cognitive disabilities, and an 
increased risk for pre- and postnatal mortality1, 2. Due to the presence of multiple anomalies, it is 
estimated that approximately 5-10% of live born infants with trisomy 18 live to the first year of 
life3. A more recent population-based study reported a one-year life expectancy of 13.4%, 
however this might be attributed to more aggressive medical interventions being increasingly 
offered4. Survival past one year of life and rarely into the second decade of life has been 
reported with those individuals experiencing profound cognitive and psychomotor delays5-7. 
Individuals with mosaic trisomy 18 or partial trisomy 18, which make up approximately 7% of 
cases of trisomy 18, may display a less severe phenotype and a lower mortality rate compared to 
non-mosaic trisomy 182, 8. Because of the high mortality associated with non-mosaic trisomy 18, 
medical care has traditionally been palliative rather than aggressive, particularly regarding the 
surgical repair of birth defects.  
 
Out of the many birth defects seen in infants with trisomy 18, the issues and attitudes 
surrounding surgery on congenital heart defects (CHDs) is one that remains particularly 
controversial in the medical literature. CHDs are found in approximately 90% of infants 
affected with trisomy 18, the most common being ventricular septal defects (VSD), atrial septal 
defects (ASD) and patent ductus arteriosi (PDA)9-11 while 10% have more complex CHDs12. 
Heart failure secondary to an unrepaired cardiac defect is considered one of the major causes of 
deaths in infants with trisomy 18 along with respiratory failure or central apnea1, 2, 13. Due to the 
co-morbidities of this condition, aggressive interventions such as cardiac surgery have 
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historically been strongly discouraged14. Numerous studies15-18 have provided justification for 
palliative approaches over surgery, raising concerns such as heart surgery being a poor 
allocation of the institution’s time and resources, harm to the infant during the recovery process 
such as pain during or post-surgery, limited maternal bonding, harsh environmental stressors, 
and disturbed sleep wake cycles. Other expressed considerations involve the ethical concerns 
surrounding surgery for infants with trisomy 18 such as nonmaleficence, beneficence, and 
justice, the quality of life after surgery, lack of clarity as to whether cardiac surgery truly 
improves prognosis, and potentially providing false or unrealistic expectations for the families. 
 
Despite these views traditionally discouraging surgical intervention, in the last decade 
numerous studies11, 19-22 have described outcomes following cardiac surgery on infants with 
trisomy 18, most frequently on VSDs, ASDs, and PDAs demonstrating seemingly favorable 
results. One study22 found that children with trisomy 18 had a two-year survival rate of 45% 
after cardiac surgery and another study23 through the Pediatric Cardiac Care Consortium 
reported an 86% hospital survival rate in infants with trisomy 18 following surgical repair of a 
CHD. While there are published recommendations regarding the importance of conversations 
between clinicians and families regarding the option of cardiac surgery24, there is an overall lack 
of agreement in the published literature for recommendations of cardiac surgery over palliative 
approaches for moderately complex cardiac defects in infants with trisomy 1823, 25. Although 
numerous studies do claim cardiac surgery potentially helps negate cardiac-related death and 
has the potential to improve the survival length of infants with trisomy 18 compared to infants 
that receive palliative care, many argue that more data demonstrating there is a clinical benefit 
to cardiac surgery needs to be published before generalizations can be made on whether or not 
to offer surgery15, 20, 21, 26, 27. Furthermore, it is important to carefully consider the limitations of 
the data available on the survival statistics of infants who undergo cardiac surgery. Confounders 
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may include selection bias of infants who undergo cardiac surgery as they are often selected 
based on less severe heart defects, absent or mild additional anomalies, and older ages. Most 
authors on both sides this subject agree that it is unrealistic to conclude that there will be a 
straightforward answer to this question, as each infant with trisomy 18 and his or her family will 
need to be considered on an individual basis, not grouped into a syndrome or diagnosis12, 27-31. 
Ultimately, the decision for an infant to undergo cardiac surgery is controversial and requires 
careful consideration and a thorough understanding by involved clinicians of the benefits and 
limitations of such intervention.  
 
As this topic has increasingly gained interest within the medical community, research 
has been performed examining the attitudes of physicians regarding the care and management of 
infants with trisomy 18. Two different studies on the opinions of neonatologists towards 
neonatal resuscitation for infants with trisomy 18 found that the expressed wishes of the parents 
largely drove the decision to perform resuscitation, a finding in favor of parental autonomy as 
opposed to a strict, palliative care approach32, 33. Other studies reinforce this, reporting that the 
majority of physicians, including obstetricians and gynecologists (OBGYN), maternal fetal 
medicine specialists (MFM), neonatologists, medical geneticists, and cardiologists, identified 
that they were likely to respect parental autonomy regarding management decisions in 
conditions such as trisomy 18 rather than making management decisions based solely on the 
diagnosis itself24, 34-37. While some consistencies have been found among physicians, these and 
other studies have further identified differences in opinions among and between specialties 
regarding the care and management of infants with trisomy 18. For example, in one study36 
cardiologists were more likely to recommend interventions including cardiac surgery for infants 
with trisomy 18 than neonatologists or medical geneticists. Conversely, another study37 
surveying cardiologists in Canada, respondents were more likely to recommend palliative care 
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and medical treatment of symptoms, not surgical repair of cardiac defects. In another, pediatric 
pulmonologists were more likely to offer interventions such as full code resuscitation and 
cardiac surgery compared to neonatologists38. These differing opinions among physicians 
suggests there is not a uniformly accepted standard of care for infants with trisomy 18. 
Therefore, decision-making surrounding the care and management of these infants should be 
considered on an individual basis and should not be grouped into a syndrome or diagnosis 
without consideration of the individual infant24, 35-37. As many clinicians are involved in the pre- 
and postnatal care of infants with trisomy 18 and the discussions with families, additional 
research is warranted to add to previously described clinicians’ attitudes towards this 
controversial topic in the interest of improving understanding of clinical approach and 
promoting consistency. When trisomy 18 is diagnosed prenatally, the patient has the option to 
continue or terminate the pregnancy. For those who decide to continue the pregnancy, 
discussions of prenatal and postnatal management options should take place between the patient 
and her healthcare team. These conversations may involve the following specialists: the 
OBGYN likely to be involved with the delivery process, MFM, neonatologist, prenatal and 
pediatric genetic counselor and medical geneticist, pediatrician, cardiac specialist in the event 
surgery is being considered, and depending on the needs of the family, sometimes a chaplain, 
clinical social worker, or home care providers such as nurses and therapists30. While all of these 
clinicians are important in the care of families with infants of trisomy 18, our study chose to 
focus on the attitudes of OBGYNs, MFMs, neonatologists, medical geneticists, genetic 
counselors, cardiologists, and cardiac surgeons. 
 
The topic of cardiac surgery for infants with trisomy 18 is undeniably a very 
complicated subject in the medical literature and clinical practice, as clinicians strive to provide 
high standards of patient care while balancing allocation of resources, parental autonomy, and 
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the best interest of the patient. As no official recommendations exist, guidance for clinicians 
involved in the pre- and postnatal care of these infants remains limited. Thus, the current 
discussions with the families may be based on outdated literature or simply lack of knowledge 
of the available options. Some studies point to the effectiveness and potential benefit of cardiac 
surgery, while others state that such data is far too limited to draw conclusions about improved 
outcomes. Such discrepancies ultimately lead to a lack of consistency among clinicians 
throughout the country and the care given to patients. We aim to improve understanding of why 
and how some clinicians choose to incorporate the options of cardiac surgery into their 
discussion, and why others do not, as well as variables that cardiac surgeons may view as 
influential when considering the surgical candidacy of a patient. By exploring these attitudes, 
we hope to further stimulate conversations within and among specialties, members of the 
healthcare team, and perhaps eventually professional societies to promote consistency in the 
discussions among families and their healthcare team to improve patient care. Thus, this study 
aims to describe clinicians’ attitudes towards cardiac surgery and infants with trisomy 18 and 
additionally to identify approaches used by cardiac surgeons in determining surgical candidates.   
METHODS 
Study Participants 
Clinicians in the following specialties were eligible for participation: OBGYNs, MFMs, 
neonatologists, medical geneticists, genetic counselors, cardiologists, and cardiac surgeons. This 
study was approved by the Institutional Review Board of the University of Texas MD Anderson 
Cancer Center UTHealth Graduate School of Biomedical Sciences (HSC-MS-16-0454). Genetic 
counselors were recruited via a survey link electronically distributed to members of the National 
Society of Genetic Counselors listserv. Physicians were recruited through genetic counselors 
affiliated with fetal centers across the United States. Genetic counselors disseminated the survey 
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link by emails to the eligible physicians at their respective institutions. Additionally, physicians 
were recruited through electronic distribution of the survey link via membership of the North 
American Fetal Therapy Network. Lastly, physicians that were reached by the methods listed 
above were given approval to distribute the survey link to their colleagues in the eligible 
specialty that were not already captured by previously implemented data collection methods. 
The study consent was present at the beginning of the survey on Qualtrics in the form of a letter 
of invitation. Completion of the survey was considered consent. Specific recruitment dates 
varied by data collection method, with responses collected from August to December 2016. 
 
Anonymous Survey  
The survey consisted of questions regarding demographics of the clinicians, general 
questions about knowledge of and experience with patients with trisomy 18, and clinicians’ 
attitudes towards reasons against and for offering cardiac surgery for infants with trisomy 18. 
Cardiac surgeons were additionally asked questions about the types of heart defects on which 
they would perform surgery on infants with trisomy 18 and if the presence of additional 
anomalies would impact their decision to perform such surgery. Participants were asked to 
respond to the questions in this survey specifically for non-mosaic trisomy 18. The question 
formatting consisted of multiple choice, “agree” or “disagree,” and Likert scale questions on a 
scale of 1 (strongly disagree) to 5 (strongly agree) including the option of “neutral.” For the 
purpose of data analysis and throughout this paper, clinicians who indicated they “strongly 
disagree” or “disagree” with the statement have been grouped together and will be referred to as 
“disagreeing,” while clinicians who indicated they “strongly agree” or “agree” with the 
statement will be referred to as “agreeing.” Free text boxes were available for additional 
comments which were included to obtain exploratory data that may lead to hypothesis-building 
and future studies. A formal validated measure was not used as survey questions were uniquely 
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developed by the authors for the purpose of this study and were reviewed by clinicians in each 
of the specialties of interest. 
 
Data Analysis 
Responses were managed using Qualtrics and were stored at the McGovern Medical 
School. STATA 13.1 statistical software was used for data analysis. Descriptive statistics were 
used to describe the results of all clinicians, while quantitative statistical comparisons were 
analyzed between the following clinician types: prenatal physicians (including OBGYNs and 
MFMs), postnatal physicians (including neonatologists, medical geneticists, cardiologists, and 
cardiac surgeons), and genetic counselors. This latter comparison was chosen based on the 
substantial number of genetic counselor respondents compared to other specialties to account 
for the difference in number of participants. Statistically significant relationships for Likert scale 
variables were determined by analyzing the three comparison groups using Kruskal Wallis tests 
and between two groups using Mann Whitney ranked sum tests. Categorical variables were 
compared using contingency tests (Fisher exact or Chi-square). A p-value of <0.05 was 
considered statistically significant.   
 
Free responses were individually reviewed and classified for common themes that were 
presented by the clinicians. These classifications were independently performed by two authors 
(MK and RC) and represented a degree of agreeability. Secondary qualitative assessments were 
made of these responses to identify themes and topics that were raised by clinicians.  
 
RESULTS 
A total of 378 clinicians participated in this survey which included 253 genetic 
counselors, 72 MFMs, 22 medical geneticists, 14 neonatologists, 8 cardiologists, 6 cardiac 
surgeons, and 3 OBGYNs. Participants who completed only the demographic section of the 
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survey were excluded from data analysis. Response rate was difficult to determine due to the 
multiple methods of data collection and the independent discretion of the genetic counselors that 
were asked to disseminate the survey to physicians associated with their institution. 
 
Demographics 
The majority of clinicians were female (86%), Non-Hispanic white (91%) working in 
university based hospital practices (58%) or non-university based hospital practices (29%). 
Forty-five percent of clinicians were between 25-34 years of age with ages ranging from 18-24 
through 65 or older. The majority (69%) of clinicians reported they see 1-5 patients with 
trisomy 18 per year. Of the clinicians who indicated they see at least one patient with trisomy 18 
on average per year, 50% reported they discussed the option of cardiac surgery with at least one 
of their patients, while 46% indicated they did not have the discussion with any of the patients 
with trisomy 18. Please see Table 1 below for additional demographic information. 
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Table 1: Demographics of clinicians (n=378) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age (n=371) n (%) Specialty (n=378) n (%) 
    18-24  20 (5)     Genetic counselors 253 (67) 
    25-34 168 (45)         Prenatal 149 (59) 
    35-44 84 (23)         Pediatrics 55 (22) 
    45-54 63 (17)         Prenatal/Pediatrics 36 (14) 
    55-64 27 (7)         Other (cancer, lab, industry, etc) 13 (5) 
    65 or older 9 (3)     Maternal fetal medicine specialists 72 (19) 
       Medical geneticists  22 (6) 
Gender (n=375) n (%)     Neonatologists 14 (4) 
    Female 323 (86)     Cardiologists 8 (2) 
    Male 52 (14)     Cardiac surgeons 6 (1) 
           Congenital heart surgery  6 (100) 
Ethnicity (n=378) n (%)     Obstetricians and gynecologists 3 (1) 
    Non-Hispanic white 345 (91)    
    Asian 11 (3) Years in Current Specialty (n=378) n (%) 
    African American 4 (1)     Less than 5 years 168 (45) 
    Other 18 (5)     5-10 years 72 (19) 
       11-15 years 46 (12) 
Region of the United 
States (n=370) 
n (%)     16-20 years 
    More than 20 years 
35 
57 
(9) 
(15) 
    South 114 (31)        
    Midwest 
    West 
98 
75 
(27) 
(20) 
Years since medical/genetic counseling 
degree (n=376) 
n (%) 
    Northeast 66 (18)     Less than 5 years 134 (36) 
    Other 17 (4)     5-10 years 86 (23) 
       11-15 years 40 (10) 
Setting of Practice 
(n=375) 
n (%)     16-20 years 
    More than 20 years 
35 
81 
(9) 
(22) 
    University-based 218 (58)        
    Non-university based 
    Private practice 
108 
30 
(29) 
(8) 
Patients seen (on avg/year) with  
dx of non-mosaic trisomy 18 (n=378) 
n (%) 
    Other 19 (5)     None 40 (11) 
       1-5 262 (69) 
       6-10 59 (16) 
           11 or more 15 (4) 
       Not sure 2 (0) 
      
   Patients (on avg/year) with non-mosaic 
trisomy 18 with whom cardiac surgery was 
discussed (n=321) 
n (%) 
       None 149 (46) 
       1-5 156 (49) 
       6-10 5 (2) 
       11 or more 4 (1) 
       Not sure 7 (2) 
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General Knowledge and Attitudes Towards Trisomy 18 
Sixty-nine percent of clinicians accurately answered that 5-10% of infants with trisomy 
18 survive beyond one year when asked about the average postnatal lifespan. More prenatal 
physicians (36%) inaccurately recalled the average postnatal lifespan to be less than 1% survive 
beyond one year compared to postnatal physicians (32%) genetic counselors (23%). Nearly half 
of all clinicians (n=357, 48%) agreed that discussing the option of cardiac surgery is 
appropriate, while thirty percent of clinicians disagreed. When stratified by clinician type 
(prenatal physicians vs. postnatal physicians vs. genetic counselors), there was a significant 
trend (p<0.001) where postnatal physicians were more likely to agree (n=48, 44%) compared to 
prenatal physicians (n=73, 29%) about the appropriateness of discussing the option of cardiac 
surgery. Fifty-nine percent of all clinicians (n=356) agreed that the discussion of cardiac surgery 
is within their scope of practice. When asked if insurance companies should cover the cost of 
cardiac surgery, overall about a third each of all clinicians agreed (30%), disagreed (33%), or 
were neutral (37%). Prenatal physicians were statistically more likely to disagree about 
insurance coverage for surgery (n=73, 59%) than postnatal physicians or genetic counselors, 
23% and 27% respectively (p<0.001).  
 
Clinicians were asked about their attitudes towards the following terms being used to 
describe individuals with trisomy 18: vegetative, incompatible with life, lethal anomaly, and 
life-limiting. Most clinicians disagreed with the use of vegetative (n=356, 68%), while across all 
specialties most clinicians agreed with the term life-limiting (n=357, 93%). When stratified by 
clinician type, more prenatal physicians agreed with use of the term vegetative (n=73, 38%) 
compared to postnatal physicians (n=48, 27%) and genetic counselors (n=235, 10%) although 
the differences were not statistically significant. Prenatal physicians were statistically more 
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likely to agree with use of the term “incompatible with life” (n=73, 52%) compared to postnatal 
physicians (n=48, 29%,) and genetic counselors (n=235, 32%) (p=0.026).  
 
General Questions Towards Cardiac Surgery for Infants with Trisomy 18 
 Clinicians were asked whether they agreed or disagreed with statements regarding the 
end benefit of cardiac surgery for infants with trisomy 18. Over half of all clinicians agreed with 
the following potential benefits: parental autonomy is respected (n=345, 91%), potential 
extension of time with their infant (n=344, 81%), and the potential for improved quality of life 
(n=339, 51%). Thirty-seven percent of clinicians (n=345) felt there was “no end benefit” in 
performing cardiac surgery. When stratified by clinician type, prenatal physicians (58%) were 
more likely to agree that cardiac surgery has “no end benefit” than other clinician types 
(p<0.001). Prenatal physicians were statistically more likely to disagree that cardiac surgery has 
the potential to extend the time with their infant (37%, p<0.001) and could potentially improve 
the infant’s quality of life (68%, p=0.002). With the option to select all that apply, clinicians 
(n=347) indicated that first hand clinical experiences (64%), medical/genetic counseling school 
training (59%), discussions with colleagues (57%), and parental autonomy (42%) influence their 
recommendations towards cardiac surgery. Thirty percent (n=287) of clinicians reported their 
current approach with patients includes discussing cardiac surgery if brought up by parents, 
emphasizing it may be an option, and providing a referral to cardiac surgery, while 28% 
(n=295) indicated their current approach includes discussing if brought up by parents but 
emphasizing surgery is discouraged. Forty-six percent (n=347) of clinicians indicated their 
approach has not changed over time meaning clinicians who have always discussed the option, 
still discuss, while clinicians who have not discussed the option, still do not discuss. The 54% of 
clinicians whose approach has changed over time indicated it was due to clinical experiences 
(21%), discussion with colleagues (21%), and new literature on the topic (12%). Of the formerly 
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28%
37%
38%
44%
47%
49%
51%
54%
56%
58%
59%
65%
71%
19%
19%
26%
36%
26%
25%
23%
23%
20%
19%
29%
24%
13%
53%
44%
36%
20%
27%
26%
26%
23%
24%
23%
12%
11%
16%
Not uniformly lethal
Expression of parental wishes
Cost to society is burdensome
Can have a general acceptable quality of life
Inappropriate allocation of time and resources
Deserve access to same interventions 
Will not improve quality of life
Causes infant pain and suffering
Provides false hope for family
Parents alone should judge risk-benefit ratio
Insufficient outcome data
High perioperative mortality
General unacceptably high mortality
Should Not Offer Surgery Neutral Should Offer Surgery
mentioned 48% of clinicians (n=347) who felt cardiac surgery is appropriate to discuss with 
patients, 74% indicated their approach would be to discuss surgery and/or refer the patient to 
cardiac surgery. Of the clinicians who felt the discussion of cardiac surgery was inappropriate 
(30%), 11% indicated they would still discuss surgery and/or refer the patient to cardiac surgery. 
 
Attitudes Regarding Considerations in Offering Cardiac Surgery 
 Over half of all clinicians (n=346-356) agreed with the following reasons as 
justifications to not offer cardiac surgery for infants with trisomy 18: condition has a general 
unacceptably high mortality (71%), high perioperative mortality (65%), insufficient outcome 
data and on risks and benefits of surgery (59%), parents alone should judge risk-benefit ratio of 
surgery (58%), provides false hope for the family (56%), causes infant pain and suffering 
(54%), and surgery will not improve the infant’s quality of life (51%) (Figure 1).  
 
Figure 1: Clinician attitudes towards considerations surrounding cardiac surgery for 
infants with trisomy 18 (n=346-356) 
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When clinicians were asked about societal costs of cardiac surgery for these infants, 47% of 
clinicians agreed that surgery should not be offered due to surgery being an inappropriate 
allocation of the institution’s time and resources and 38% agreed that the cost of surgery to 
society is burdensome as reasons not to offer cardiac surgery. Overall when stratified by 
clinician types, prenatal physicians tended to be more likely to indicate surgery should not be 
offered compared to postnatal physicians and genetic counselors, who tended to have more 
equal distributions between agreeing, disagreeing, and neutral (Table 2). 
 
Table 2: Comparison of attitudes towards considerations in offering cardiac surgery by 
clinician type (prenatal physicians (n=75), postnatal physicians (n=50), genetic counselors 
(n=253)) 
 Should Not Offer 
Surgery Neutral 
Should Offer 
Surgery 
Reasons Regarding Offering Cardiac Surgery    
   *General unacceptably high mortality (p<0.001)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
85% 
54% 
71% 
5% 
17% 
14% 
10% 
29% 
15% 
   *High perioperative mortality (p<0.001)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
64% 
42% 
69% 
32% 
31% 
21% 
4% 
27% 
10% 
    Insufficient outcome data (p=0.262)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
50% 
54% 
63% 
43% 
17% 
26% 
7% 
29% 
11% 
    Parents alone should judge risk-benefit ratio (p=0.319)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
64% 
78% 
52% 
13% 
7% 
24% 
23% 
15% 
24% 
   *Provides false hope for family (p<0.001)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
67% 
61% 
52% 
18% 
10% 
22% 
15% 
29% 
26% 
    Causes infant pain and suffering (p=0.086)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
62% 
58% 
51% 
20% 
19% 
24% 
18% 
23% 
25% 
   *Will not improve quality of life (p=0.021)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
58% 
54% 
48% 
27% 
19% 
22% 
15% 
27% 
30% 
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   *Deserve access to same interventions (p<0.001)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
71% 
67% 
39% 
20% 
13% 
29% 
9% 
20% 
32% 
   *Inappropriate allocation of time and resources (p<0.001)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
76% 
32% 
42% 
13% 
33% 
28% 
11% 
35% 
30% 
   *Can have a general acceptable quality of life (p<0.001)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
62% 
44% 
39% 
34% 
26% 
38% 
4% 
30% 
23% 
   *Cost to society is burdensome (p<0.001)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
68% 
28% 
31% 
18% 
36% 
26% 
14% 
36% 
43% 
    *Expression of parental wishes (p=0.034)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
57% 
59% 
27% 
20% 
19% 
18% 
23% 
22% 
55% 
   *Condition is not uniformly lethal (p=0.007)    
        Prenatal physicians 
        Postnatal physicians 
        Genetic counselors 
53% 
37% 
19% 
17% 
26% 
18% 
30% 
37% 
63% 
 
One exception was in regard to insufficient research on risks and benefits. Genetic counselors 
were more likely to agree (63%) than prenatal (50%) and postnatal physicians (42%) with 
insufficient outcome data as a reason to not offer cardiac surgery. The differences were 
statistically significant between prenatal physicians, postnatal physicians, and genetic 
counselors for all provided considerations regarding cardiac surgery with the exception of 
insufficient outcome data, the risks and benefits of surgery, parents alone should judge the risk-
benefit of surgery, and surgery causes the infant pain and suffering. Please see Table 2 for 
additional information.    
 
 Fifty-three percent (n=347) of clinicians across all specialties agreed that trisomy 18 not 
being uniformly lethal is a reason to offer cardiac surgery (Figure 1). This was the sole 
consideration on which the majority of all clinicians agreed in support of offering surgery. Of all 
clinicians, 44% agreed that surgery should be offered if parents express their wish to have 
“everything done” for their child. When stratified into clinician type, genetic counselors were 
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twice as likely to agree (55%) with surgery being offered due expression of parental wishes 
compared to prenatal and postnatal physicians, 23% and 22% respectively (p=0.034). Overall 
26% of clinicians felt surgery should be offered because infants with trisomy 18 deserve access 
to the same interventions as chromosomally typical infants compared to 49% who disagreed; 
further analysis revealed that genetic counselors were statistically more likely to agree (32%) 
with this statement as justification for offering surgery than prenatal and postnatal physicians 
(9% and 20% respectively) (p<0.001). Twenty percent of clinicians agreed that individuals with 
trisomy 18 having an acceptable quality of life was a reason to offer cardiac surgery, while 36% 
were neutral. Postnatal physicians and genetic counselors were more likely to agree (30% and 
23%) with this statement as a justification to offer surgery than prenatal physicians (4%) 
(p<0.001).  
 
Cardiac Surgeon Approaches to Determining Candidates for Cardiac Surgery 
 Four out of six cardiac surgeons reported they had performed cardiac surgery on at least 
one infant with trisomy 18; the two cardiac surgeons that had not performed surgery indicated 
they would be willing to do so. Most cardiac surgeons indicated they would be willing to 
perform surgery on an infant with trisomy 18 for the following heart defects: VSD (5/6), PDA 
(5/6), coarctation of the aorta (5/6), and ASD (4/6) while none of the cardiac surgeons indicated 
they would be willing to perform surgery on infants with trisomy 18 and hypoplastic left heart 
syndrome (Table 3).  
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Table 3: Cardiac surgeons’ willingness to perform surgery on infants with trisomy 18 
depending on the type of heart defect and the presence of additional anomalies (n=6) 
 
 
 
 
 
 
 
 
 
 
 
In an infant with trisomy 18 with a heart defect described to be of mild to moderate complexity, 
most cardiac surgeons were still willing to perform surgery in the presence of additional 
anomalies including clubfoot (5/6), polydactyly (5/6), and cleft lip with or without cleft palate 
(4/6). Fewer reported willingness to perform surgery as the severity of the anomaly increased, 
with no cardiac surgeons (0/6) willing to perform surgery with the additional finding of a 
diaphragmatic hernia. All cardiac surgeons selected gestational age, birth weight, the 
complexity of the heart defect, and presence of additional anomalies as influential factors in 
determining appropriate candidates for surgery. The gender of the infant was found to be the 
least influential factor in determining candidacy for surgery (Figure 2). 
 
 
Type of Heart Defect Willing to Perform Surgery (n) 
    Ventricular septal defect 5 
    Patent ductus arteriosus 5 
    Coarctation of the aorta 5 
    Atrial septal defect 4 
    Tetralogy of fallot 3 
    Pulmonary stenosis 3 
    Atrioventricular septal defect 2 
    Transposition of the great arteries  1 
    Double outlet right ventricle 1 
    Hypoplastic left heart syndrome  0 
Anomalies Present in Addition  
to Heart Defect 
Willing to Perform Surgery (n) 
    Clubfoot 5 
    Polydactyly 5 
    Cleft lip +/- palate 4 
    Spina bifida 3 
    Omphalocele 2 
    Esophageal atresia 1 
    Diaphragmatic hernia 0 
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Figure 2: Cardiac Surgeons’ attitudes towards the influence of other factors in their 
willingness to perform cardiac surgery on infants with trisomy 18 (n=6) 
 
 Half of cardiac surgeons (3/6) indicated their decision to perform cardiac surgery on infants 
with trisomy 18 is made on a “case by case basis” while the other half (3/6) indicated the 
decision is made at the discretion of the attending team. 
 
Free responses 
 Of the clinicians in our study, 29% left free responses (n=108). A total of 158 free 
responses were recorded, as many clinicians left more than one free response. A topic that was 
brought up most by clinicians (approximately 40%) in the free responses was that the 
appropriateness of offering cardiac surgery for an infant with trisomy 18 should depend on the 
clinical picture of the infant.  
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 “Decisions about intervention should be made on the individual child's situation, not a 
blanket decision based on chromosomal diagnosis.” – Medical geneticist 
 “I feel that the decision to pursue cardiac intervention for patients with [trisomy 18] is a 
very personal decision that should be made collaboratively with both the patient and the care 
team. If the patient is relatively stable and is healthy enough to undergo cardiac intervention 
without almost definite outcomes of death during surgery, the family should be offered 
intervention. The value of added days, weeks or years of life expectancy as well as the quality of 
a child's life should not be determined by care providers alone but together with the family.” - 
Neonatologist 
 “[Performing surgery] depends on the surgery. If it is "palliative”… to relieve 
symptoms and/or [only] one surgery...then it might be fine. For complex lesions…surgery 
should not be offered.” – Cardiologist 
Another frequently encountered topic pertained to the parents being adequately informed of the 
risks and benefits of surgery before making a decision.  
 “If extensive counseling is performed and the parents appear to understand the 
limitations of such care, and the care is available.. it may be appropriate to have this 
discussion.” – MFM 
 “Parents should be provided with factual information and have access to a counselor 
who can guide them through the process of making a decision that fits with what they want for 
their child.” – Medical geneticist 
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 “I feel like a thorough discussion with the parents regarding why they wish for cardiac 
intervention is ESSENTIAL.” – Genetic counselor 
Many clinicians brought up the overall cost of surgery including societal burden and the 
emotional and financial cost to the family.  
 “[Cardiac] surgery could diminish any quality time the parents could expect with these 
very disabled children for no real expectation of long term benefit.” – MFM 
 “Raising the unnecessary cost of medical care to society just because you can is a 
disservice to society.” – MFM 
 “What cardiac surgery does in many cases is to prolong the life in the hospital at the 
expense of the family.” – Medical geneticist 
Lastly, clinicians indicated that cardiac surgery may potentially improve the outcome of the 
infant with trisomy 18.   
 “There may be some instances where palliative procedures reduce suffering but do not 
necessarily prolong life, which may be an acceptable intervention.” – MFM 
 “Many of the cardiac defects result in increased work of breathing which results in 
respiratory distress. Repairing these can alleviate some degree of suffering [for the infant]” – 
Cardiologist 
 “[Surgery] could optimize quality of life for the time the infant has available.” – 
Cardiac surgeon 
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DISCUSSION 
The appropriateness of offering cardiac surgery to families of infants with trisomy 18 is 
undoubtedly complex and has been met with a wide range of opinions in the literature. Our 
study describes clinician attitudes surrounding this topic while further demonstrating the 
variability in opinions of various clinicians often involved in the care and counseling of these 
families. Our results suggest that nearly half of clinicians in our study feel it is appropriate to 
discuss the option of cardiac surgery with postnatal physicians and genetic counselors feeling it 
is more appropriate for this discussion to take place than prenatal physicians. Of clinicians who 
feel this discussion is appropriate, the vast majority are discussing the option of surgery and/or 
referring the patient to cardiac surgery for such a discussion to take place. This clinical approach 
of discussing cardiac surgery supports recent literature pointing to the fact that cardiac surgery 
for infants with trisomy 18 is occurring more frequently than previously reported36. Few 
clinicians who responded that the discussion of cardiac surgery is inappropriate still report 
discussing and/or referring their patients to cardiac surgery. Interestingly, a quarter of clinicians 
felt the discussion was appropriate, however indicated that they do not discuss the option of 
cardiac surgery. This suggests there may be barriers that clinicians experience regarding the 
discussion of cardiac surgery, however these potential barriers that may exist were not formally 
explored in our study. Several respondents stated lack of accessibility to willing surgeons in the 
free responses as further explanations for why the option is not offered to their patients; 
exploration of this and other barriers is warranted through formal study. Overall, our study 
provides evidence that there are clinicians across multiple sub-specialties who feel the 
discussion of cardiac surgery is appropriate and report actually having such discussions with 
families and referring them to cardiac surgery. 
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There is limited research in current literature examining clinician attitudes towards the 
use of a wide range of terms to describe individuals with trisomy 18. These terms range from 
less patient friendly descriptions such as vegetative, incompatible with life, and lethal anomaly 
to the more patient friendly term life-limiting, which were included based on literature regarding 
communicating with families about trisomy 18 as well as other severe conditions24, 39-41. While 
overall most clinicians disagreed with the less patient friendly terms (vegetative and 
incompatible with life) and agreed with the most patient friendly term (life-limiting), prenatal 
physicians were more likely to agree with the less sensitive terms when compared to postnatal 
physicians and genetic counselors.  
One challenge families of infants with trisomy 18 face is the inconsistency between 
prenatal and postnatal counseling by their medical team. Our study shows evidence that prenatal 
physicians have significantly different perceptions of trisomy 18 compared to our other clinician 
groups. We found that prenatal physicians were more likely to agree with use of less patient 
friendly terms to describe the prognosis of trisomy 18 (specifically incompatible with life) and 
were slightly more likely to indicate infants with trisomy 18 have a shorter lifespan than current 
literature supports. Additionally, prenatal physicians were more likely to consider surgery to 
have no end benefit and less likely to consider surgery may have the potential to extend time 
with infant or improve the infant’s quality of life. Overall, prenatal physicians reported less 
support of the discussion of the option of cardiac surgery for these infants compared to postnatal 
physicians and genetic counselors. While we cannot ascertain from our study the reason prenatal 
physicians responded more unfavorably towards trisomy 18 than postnatal physicians and 
genetic counselors, we can speculate based on the nature of the patients and care these clinicians 
provide in their respective specialties. For those working with families following a prenatal 
diagnosis, 72% of those pregnancies will result in miscarriage or stillbirth42 thus the majority 
may feel the discussion of surgery is inappropriate and irrelevant to the majority of the 
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pregnancies they encounter due to the high percentage of prenatal and perinatal deaths. 
Conversely, postnatal physicians are more likely to encounter the 28% of infants with trisomy 
18 who have survived delivery and potentially the neonatal period and thus may represent the 
less severely affected cases where potentially the discussion of cardiac surgery is more 
appropriate and relevant. These experiences of clinicians may in turn affect the perception of 
these clinicians towards trisomy 18 in general and regarding the appropriateness of discussing 
the option of cardiac surgery. 
 
In our study, clinician attitudes were examined around common themes that have 
emerged in previous literature15-18, 24. These themes included ethical considerations such as 
access to interventions, the general high mortality of trisomy 18, potential for pain and suffering 
of infant during and post-surgery, high perioperative mortality of surgery, and providing false 
hope to the family, as well as other themes including societal costs, insufficient outcome data, 
issues surrounding quality of life, and parental autonomy. In general, our study provides 
evidence that there is clinician support of the discussion of the option cardiac surgery. However, 
many clinicians still expressed discomfort with offering cardiac when considering the lack of 
outcome data and reasons surrounding ethical principles such as nonmaleficence, beneficence, 
and justice. These findings support and further validate numerous studies15-17 that have 
expressed hesitancy in performing or offering cardiac surgery for infants with trisomy 18 when 
considering ethical issues and insufficient outcome data. Clinicians indicating that ethical 
concerns surrounding offering surgery were justifications against offering surgery was 
unsurprising as ethical concerns surrounding this topic are undeniably an important and 
recurrent topic in discussions between clinicians and with families when deciding if cardiac 
surgery is appropriate24. Dissimilarly, several studies15, 29 have pointed to the societal burden of 
performing cardiac surgery for these infants as a clear reason against offering surgery; however 
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more clinicians in our study felt surgery should still be offered or were neutral regarding societal 
burdens of cardiac surgery than felt societal burdens were a reason against offering surgery. 
There was also no consensus among clinicians when asked if insurance companies should cover 
the cost of surgery. Therefore, it may be that the potential burden to society that others have 
suggested is not uniformly felt by clinicians in our study as a reason not to offer surgery. 
 
The consideration of trisomy 18 not being uniformly lethal was the sole reason upon 
which more than half of clinicians agreed cardiac surgery should be offered. This finding is 
consistent with a notable shift in the literature emphasizing that trisomy 18 should not be 
presented as a lethal anomaly in the counseling of families given the known survivability2, 40, 43. 
Previous studies32, 33 have suggested that parental autonomy provides an impact regarding 
management decisions made by clinicians, however the results of our study demonstrated mixed 
feelings toward parental involvement. Over half of clinicians in this study disagreed or were 
neutral regarding expressed parental wishes as a reason to offer cardiac surgery, however, the 
great majority of clinicians in our study felt that an end benefit to performing surgery is that 
parental autonomy is respected. This implies that clinicians in our study may or may not feel 
that parental autonomy sway their decisions to offer cardiac surgery, but they did agree that 
parental autonomy had a place as a potential benefit of performing surgery.  
Most clinicians “strongly disagreed” with parents alone judging the risk-benefit ratio of 
cardiac surgery as a reason to offer cardiac surgery than all other reasons provided. This was 
further illustrated by multiple free response comments expressing that allowing parents alone to 
weigh the risks and benefits of surgery takes away from the valuable medical expertise and 
experience clinicians provide. These findings support the “shared decision making approach” 
suggested in previous literature, which describes an approach to care that involves the values 
24 
and wishes of the families as well as the medical knowledge and expertise of clinicians of 
multiple subspecialties30.  
 
Our study also aimed to describe cardiac surgeons’ approaches to determining candidacy 
for cardiac surgery among infants with trisomy 18. Due to the small number of cardiac surgeons 
who participated in this survey, we are unable to draw conclusions but can make general 
comments on the responses received from the surgeons in our study. With regard to the heart 
defect complexity, as expected, more cardiac surgeons in our study were willing to perform 
surgical repair on mild to moderate complex heart defects such as VSDs, PDAs, and 
coarctations of the aorta, while less were willing to perform surgery for increasingly complex 
heart defects such as transposition of the great arteries and double outlet right ventricle and none 
were willing to perform surgery on the complex hypoplastic left heart syndrome. This is 
consistent with previous studies11, 19-23 that have described repairs of congenital heart defects in 
infants with trisomy 18, suggesting that they are the heart defects most operated on of those 
reported. Cardiac surgeons were less likely to be willing to perform surgery in the presence of 
additional worsening anomalies such as esophageal atresia and congenital diaphragmatic hernia, 
which even when found in isolation have higher postoperative morbidity and mortality 
compared to other anomalies such as polydactyly and cleft lip with or without cleft palate44, 45. 
Cardiac surgeons indicated that other factors such as gestational age and birth weight were 
influential along with the complexity of the heart defect and presence of other anomalies when 
considering an infant for cardiac surgery. The specific aspects of gestational age and birth 
weight were not described; future studies may allow surgeons to expand upon this further with 
insights into their attitudes towards acceptable birth weights and gestational ages at time of 
delivery. Overall, these findings suggest cardiac surgeons are most willing to perform surgery 
on mild to moderate heart defects in the absence of additional anomalies or presence of 
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additional anomalies associated with lower morbidity rates. Further, our study found that all 
cardiac surgeons who responded have either performed surgery or are willing to perform 
surgery, demonstrating that the option exists.  
Genetic counselors are often involved in both the pre- and postnatal discussions 
regarding the care and management for families with a diagnosis of trisomy 18. The overall 
findings of this study were that a greater majority of genetic counselors felt the discussion of 
cardiac surgery is appropriate compared to physicians. Expressed parental wishes and trisomy 
18 not being uniformly lethal were more important considerations reported by genetic 
counselors in support of offering surgery, compared to physicians. These findings support basic 
tenants of genetic counseling regarding nondirective counseling, providing balanced 
perspectives of conditions, supporting patient autonomy and decision making, and advocating 
for families. Furthermore, genetic counselors have the skills to initiate psychosocially targeted 
conversations with families and they are often able to ascertain the family’s values and wishes 
as to better understand the reasoning behind their pursuit of aggressive interventions like cardiac 
surgery for their infant. Ascertaining the family’s values and wishes, advocating for patients and 
their family as well as placing an importance on patient autonomy highlights the valuable and 
unique role genetic counselors play as part of a multidisciplinary team regarding complex 
management decisions such as the pursuit of cardiac surgery46. 
 
PRACTICE IMPLICATIONS 
Our study demonstrates the differing opinions among clinicians regarding the 
appropriateness of offering cardiac surgery. The difference is most notable when comparing 
prenatal physicians to postnatal physicians and genetic counselors. The differing opinions 
between clinicians overall and specifically with regard to prenatal physicians points to the 
importance of open communication among the specialties to ensure that providers are educated 
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on how their colleagues are approaching this option with patients. Families should be provided 
with balanced and consistent counseling on the decisions surrounding cardiac surgery to avoid 
misunderstanding and mistrust17.  
While not ascertained in previous literature for comparisons, almost half of the clinicians 
in our study indicated that they feel the discussion of cardiac surgery is appropriate and 
approximately half of the clinicians self-reported that their approach to discussing the option of 
cardiac surgery has changed over time. This suggests that attitudes are not static towards 
surgical interventions for infants with trisomy 18 and that there is potential for approaches to 
continue to evolve over time. Moreover, all cardiac surgeons in our study were willing to 
perform surgery on infants with trisomy 18 depending on the clinical picture of the infant, 
which may contradict some clinicians’ beliefs. While limitations exist with the data obtained by 
the cardiac surgeons in our study, understanding the willingness and conditions in which cardiac 
surgeons will perform surgery is another important aspect to this complex topic that further 
points to an evolving attitude.  
 
The goal of this study was not to provide recommendations for uniform care of all 
infants with heart defects and trisomy 18, as an individualized approach to care of each patient 
is paramount. Results of this study may lead to a heightened appreciation for the complexity of 
this issue for clinicians who may perceive cardiac surgery as irrelevant or believe that the barrier 
to access surgeons who are willing to perform surgery is so great that it is simply not worth 
considering. Our findings support the notion of incorporating at least recognition of the option 
of cardiac surgery in the discussion of management of infants with trisomy 18, including an 
acknowledgment that this may not be available based on the clinical picture or other center-
specific criteria, as well as giving families permission to not explore or choose this option. 
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Appropriate referrals can be provided if the discussion is beyond the clinician’s scope of 
practice, knowledge, or comfort.  
 
We hope the results of this study will be shared within and among multidisciplinary 
specialists involved in the care of infants with trisomy 18 to improve understanding of current 
practice and attitudes. By stimulating such discussions among clinicians, further education and 
informed attitudes regarding this topic among themselves and their peers will be accomplished. 
We appreciate it is unrealistic to believe clinicians will ever completely agree on offering 
surgery or not; however it is reasonable to expect clinicians to collaborate with one another in 
the care of families of infants with trisomy 18 in order to promote consistent patient care and 
open and honest discussions exploring families’ goals and wishes.  
 
STRENGTHS AND LIMITATIONS 
This study was able to describe the attitudes of both prenatal and postnatal clinicians 
surrounding their attitudes towards care of infants with trisomy 18. This is a strength of our 
study since many clinicians are involved in the care surrounding infants with trisomy 18 during 
the pre- and postnatal period, thus we were able to make comparisons. Previous literature has 
pointed to the importance for such examinations before further progress on this topic can be 
made35, 36, 38. Our study design also allowed for sampling attitudes of physicians throughout the 
country in the specialties of maternal fetal medicine and genetic counseling which aids to the 
applicability of these results.  
The sampling of physicians through fetal centers may have led to attitudes mostly 
representative of physicians in medical centers with access to more cutting edge technology and 
colleagues who are more likely to be in an academic setting practicing standards of care based 
on current literature. Therefore, our physician population (excluding MFMs) is not 
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representative of physicians at large, but rather more likely representative of physicians in an 
academic setting. 
Sample sizes for some of our physician groups were a limitation as well. While the 
postnatal physician group captured a wide spectrum of the physicians involved in the care of 
infants with trisomy 18 in the postnatal period, the prenatal physician group consisted mostly of 
MFMs (n=72) and few OBGYNs (n=3). Therefore, the results of this study and the attitudes of 
the prenatal physicians should be interpreted to be mostly representative of MFMs and cannot 
be extrapolated to the attitudes of OBGYNs. Our study does represent a broad sample of MFMs 
which is valuable since MFMs are important clinicians in high-risk pregnancies such as those 
diagnosed with trisomy 18. However, we cannot comment extensively on the attitudes of 
OBGYNs who, depending on the circumstance, may be the initial and possibly only contact for 
families when a diagnosis of trisomy 18 is suspected or confirmed. Therefore, this is a limitation 
of our study. Similarly, the six cardiac surgeons who responded to our survey practice either in 
Texas (n=4) or Missouri (n=2). Therefore, the attitudes of the cardiac surgeons in our study 
cannot be extrapolated to be representative of the attitudes and opinions of cardiac surgeons in 
general. This is, again, a limitation of our study as one of the aims was to comment further on 
the opinions of cardiac surgeons and the influential variables in determining surgical candidacy 
for infants with trisomy 18, however based on our small sample size, we are limited to sharing 
our findings and not drawing conclusions. 
Another limitation that is common to survey research is selection bias. The clinicians 
who participated in our study may be those who feel most strongly about this topic and may not 
represent the average clinician. Additionally, although we have reported qualitative assessments 
of the free responses, it should be noted that our survey was not designed as a qualitative free 
response study. Therefore, it is possible the responses were biased by the questions preceding 
them. 
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Lastly, at times the term “cardiac intervention” was used in the survey which was 
intended to be synonymous with cardiac surgery, however upon closer consideration could have 
been interpreted as palliative surgical interventions, such as pulmonary artery banding, not 
exclusively surgical repair47. While most often the actual phrase “cardiac surgery” was used, the 
following questions used “cardiac intervention”: appropriateness to discuss the option, 
appropriateness for insurance companies to cover cost, discussion is within scope of practice, 
“end benefit” questions, factors that have influenced clinicians’ recommendations, and 
questions regarding clinicians’ approaches to such discussion. Overall, we do not feel this 
discrepancy in wording heavily impacted the results and conclusions drawn from our study.  
 
FUTURE DIRECTIONS 
While our study was able to capture a variety of pre- and postnatal clinicians that are 
involved in care of these infants, the opinions of other clinicians such as pediatricians, nurses, 
and social workers would be a valuable addition to the literature in an effort to obtained 
inclusive data on the attitudes of the many clinicians involved to better understand the 
perspective of the different specialties. This would ultimately better serve families encountering 
this decision-making process in the future. Continued research is also needed on the cardiac 
conditions and influential variables impacting surgical treatment in a larger population of 
cardiac surgeons to better describe how these decisions are made. Finally, if current trends 
continue and more families are offered and pursue the option of surgery, longitudinal research 
should be done to assess these outcomes as well as the experiences of the families. This will 
provide necessary information to those clinicians still hesitant to broach this topic based on 
insufficient research on outcomes and will also provide better understanding of clinician and 
family interactions. 
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APPENDIX 
Q1 Age 
m 18 - 24 
m 25 - 34 
m 35 - 44 
m 45 - 54 
m 55 - 64 
m 65 - 74 
m 75 or older 
 
Q2 Gender 
m Male 
m Female 
 
Q3 Race/Ethnicity  
m White 
m Black or African American 
m American Indian or Alaska Native 
m Asian 
m Native Hawaiian or Pacific Islander 
m Other 
 
Q4 In what state do you currently practice? 
(select state from drop down menu)  
 
Q5 Setting of practice 
m University based hospital practice 
m Non-university hospital practice 
m Private practice 
m Other, please specify ____________________ 
 
Q6 How many years have you been in your current specialty?  
m less than 5 years 
m 5 to 10 years 
m 11 to 15 years 
m 16 to 20 years 
m more than 20 years 
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Q7 What is your specialty? 
m Obstetrics and Gynecology (skip to Q8) 
m Maternal Fetal Medicine (skip to Q8) 
m Neonatology (skip to Q23) 
m Medical Genetics (skip to Q23) 
m Genetic Counseling (skip to Q38) 
m Cardiology (skip to Q23) 
m Cardiothoracic surgery (skip to Q54) 
m Other, please specify ____________________ (skip to Q8) 
 
Q8 How many years since you have received your medical degree? 
m less than 5 years 
m 5 to 10 years 
m 11 to 15 years 
m 16 to 20 years 
m more than 20 years 
 
Q9 Please select from the choices provided your understanding of the postnatal lifespan 
of patients with non-mosaic trisomy 18: 
m No infants survive beyond one year 
m <1% survive beyond one year 
m 5-10% survive beyond one year 
m 20-25% survive beyond one year 
m I do not know 
 
Q10 How many patients with a prenatal diagnosis of trisomy 18, on average per year, 
have you participated in care for? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
m 21 or more 
m Not sure 
 
Q11 How many patients with a prenatal diagnosis of trisomy 18, on average per year, 
have you discussed cardiac intervention as a postnatal option? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
m 21 or more 
32 
m Not sure 
 
The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18 
and cardiac intervention. Please remember to consider each question in regards to a 
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.  
 
Q12 Please indicate for each of the following terms below whether you agree or disagree 
with the term being used to describe patients with trisomy 18.  
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
agree 
Life-limiting m  m  m  m  m  
Vegetative m  m  m  m  m  
Incompatible with 
life m  m  m  m  m  
Lethal anomaly m  m  m  m  m  
 
Q13 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion 
on the following statements below.  
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
It is appropriate to counsel families 
with an infant with trisomy 18 and 
a cardiac defect about the option of 
cardiac intervention. 
m  m  m  m  m  
It is appropriate for insurance 
companies to cover the cost of 
cardiac intervention for infants with 
trisomy 18. 
m  m  m  m  m  
Discussing the option of cardiac 
intervention for infants with a 
prenatal diagnosis of trisomy 18 is 
within my scope of practice. 
m  m  m  m  m  
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Q14 The below reasons have been given for NOT providing cardiac surgery on infants 
with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please indicate 
your feelings toward each statement. 
Surgery should not be offered to infants with trisomy 18 because…  
 
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
Trisomy 18 is associated with 
unacceptably high mortality. m  m  m  m  m  
It is an inappropriate allocation of 
the institution's time and resources. m  m  m  m  m  
Because the perioperative 
mortality is unacceptably high in 
these infants. 
m  m  m  m  m  
Surgery results in prolonging 
short-term life but does not 
produce a cure or affect long-term 
survival. 
m  m  m  m  m  
The cost to society for the infants 
to undergo surgery is burdensome. m  m  m  m  m  
Surgery will not improve the 
quality of the infant's life. m  m  m  m  m  
There is insufficient research done 
examining the risks and benefits to 
the infant. 
m  m  m  m  m  
Surgery causes the infant pain and 
suffering. m  m  m  m  m  
It provides false hope for the 
family. m  m  m  m  m  
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Q15 Additional reasons you feel cardiac surgery SHOULD NOT be performed on an 
infant with trisomy 18, if any.  
(open response text box) 
 
Q16 The below reasons have been given in SUPPORT of providing cardiac surgery on 
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please 
indicate your feelings toward each statement.  
 
Surgery should be offered to infants with trisomy 18… 
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
If the parents express their desire to 
have "everything done" for their 
child. 
m  m  m  m  m  
Because the infant deserves the 
opportunity for the same 
interventions offered to other 
chromosomally normal infants with 
congenital heart defects. 
m  m  m  m  m  
Because surgery may improve the 
infant's quality of life. m  m  m  m  m  
Because trisomy 18 is not uniformly 
lethal. m  m  m  m  m  
Because infants with trisomy 18 can 
have an acceptable quality of life. m  m  m  m  m  
Because parent(s) alone should 
judge risk-benefit ratio for surgery. m  m  m  m  m  
 
Q17 Additional reasons you feel cardiac surgery SHOULD be performed on an infant 
with trisomy 18, if any.  
(open response text box) 
 
Q18 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of 
this intervention is:  
 
 
 
 
 
 
 
 
 
 
 
 
 Disagree Agree 
No end benefit m  m  
Parental wishes/autonomy are 
honored m  m  
Potential for extended time with 
infant m  m  
Potential for improved quality of 
life m  m  
Other, please specify m  m  
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Q19 Which factors have influenced your recommendations towards cardiac intervention 
for infants with trisomy 18? (check all that apply) 
q Medical school training 
q First hand clinical experience 
q Discussion with colleagues 
q Parental autonomy 
q Other, please specify ____________________ 
 
Q20 Please describe your approach to discussing the option of cardiac intervention for 
infants with trisomy 18. 
m I do not discuss the option of cardiac intervention. 
m I will discuss it if brought up by the parents, but I emphasize intervention is 
discouraged. 
m I will discuss it if brought up by the parents, emphasize it may be an option, but do 
not refer to cardiac surgery. 
m I will discuss it if brought up by the parents, emphasize it may be an option, and refer 
to cardiac surgery. 
m I discuss it in all cases regardless if brought up by parents. 
m Other, please specify ____________________ 
 
Q21 If your approach to discussing cardiac intervention has changed over time, what has 
influenced this? (check all that apply) 
q My approach has not changed. 
q New literature on this topic 
q Discussions with my colleagues 
q First hand clinical experiences 
q Other, please specify ____________________ 
 
Q22 Any additional comments you have on this subject of trisomy 18 and cardiac 
intervention would be helpful.  
(open response text box) 
END OF SURVEY 
 
Q23 How many years since you have received your medical degree? 
m less than 5 years 
m 5 to 10 years 
m 11 to 15 years 
m 16 to 20 years 
m more than 20 years 
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Q24 Please select from the choices provided your understanding of the postnatal lifespan 
of patients with non-mosaic trisomy 18: 
m No infants survive beyond one year 
m <1% survive beyond one year 
m 5-10% survive beyond one year 
m 20-25% survive beyond one year 
m I do not know 
 
Q25 How many patients with a diagnosis of trisomy 18, on average per year, have you 
participated in care for? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
m 21 or more 
m Not sure 
 
 
Q26 How many patients with a diagnosis of trisomy 18, on average per year, have you 
discussed cardiac intervention as a postnatal option? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
m 21 or more 
m Not sure 
 
The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18 
and cardiac intervention. Please remember to consider each question in regards to a 
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.  
 
Q27 Please indicate for each of the following terms below whether you agree or disagree 
with the term being used to describe patients with trisomy 18.  
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
agree 
Life-limiting m  m  m  m  m  
Vegetative m  m  m  m  m  
Incompatible with 
life m  m  m  m  m  
Lethal anomaly m  m  m  m  m  
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Q28 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion 
on the following statements below.  
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
It is appropriate to counsel families 
with an infant with trisomy 18 and 
a cardiac defect about the option of 
cardiac intervention. 
m  m  m  m  m  
It is appropriate for insurance 
companies to cover the cost of 
cardiac intervention for infants with 
trisomy 18. 
m  m  m  m  m  
Discussing the option of cardiac 
intervention for infants with a 
diagnosis of trisomy 18 is within 
my scope of practice. 
m  m  m  m  m  
 
Q29 The below responses have been given for NOT providing cardiac surgery on infants 
with trisomy 18. On a scale to "strongly disagree" to "strongly agree", please indicate 
your feelings toward each statement.  
 
Surgery should not be offered to infants with trisomy 18 because…  
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
Trisomy 18 is associated with 
unacceptably high mortality. m  m  m  m  m  
It is an inappropriate allocation of 
the institution's time and resources. m  m  m  m  m  
Because the perioperative 
mortality is unacceptably high in 
these infants. 
m  m  m  m  m  
Surgery results in prolonging 
short-term life but does not 
produce a cure or affect long-term 
survival. 
m  m  m  m  m  
The cost to society for the infants 
to undergo surgery is burdensome. m  m  m  m  m  
Surgery will not improve the 
quality of the infant's life. m  m  m  m  m  
There is insufficient research done 
examining the risks and benefits to 
the infant. 
m  m  m  m  m  
Surgery causes the infant pain and 
suffering. m  m  m  m  m  
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It provides false hope for the 
family. m  m  m  m  m  
 
Q30 Additional reasons you feel cardiac surgery SHOULD NOT be performed on an 
infant with trisomy 18, if any.  
(open response text box) 
 
Q31 The below reasons have been given in SUPPORT of providing cardiac surgery on 
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please 
indicate your feelings toward each statement. 
Surgery should be offered to infants with trisomy 18… 
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
If the parents express their desire to 
have "everything done" for their 
child. 
m  m  m  m  m  
Because the infant deserves the 
opportunity for the same 
interventions offered to other 
chromosomally normal infants with 
congenital heart defects. 
m  m  m  m  m  
Because trisomy 18 is not uniformly 
lethal. m  m  m  m  m  
Because infants can have an 
acceptable quality of life. m  m  m  m  m  
Because parent(s) alone should 
judge risk-benefit ratio for surgery. m  m  m  m  m  
 
Q32 Additional reasons you feel cardiac surgery SHOULD be performed on an infant 
with trisomy 18, if any.  
(open response text box) 
 
Q33 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of 
this intervention is:  
 Disagree Agree 
No end benefit m  m  
Parental wishes/autonomy are 
honored m  m  
Potential for extended time with 
infant m  m  
Potential for improved quality 
of life m  m  
Other, please specify m  m  
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Q34 Which factors have influenced your recommendations towards cardiac intervention 
for infants with trisomy 18? (check all that apply) 
q Medical school training 
q First hand clinical experience 
q Discussion with colleagues 
q Parental autonomy 
q Other, please specify ____________________ 
 
Q35 Please describe your approach to discussing the option of cardiac intervention for 
infants with trisomy 18. 
m I do not discuss the option of cardiac intervention. 
m I will discuss it if brought up by the parents, but I emphasize intervention is 
discouraged. 
m I will discuss it if brought up by the parents, emphasize it may be an option, but do 
not refer to cardiac surgery. 
m I will discuss it if brought up by the parents, emphasize it may be an option, and refer 
to cardiac surgery. 
m I discuss it in all cases regardless if brought up by the parents. 
m Other, please specify ____________________ 
 
Q36 If your approach to discussing the option of cardiac intervention has changed over 
time, what has influenced this? (check all that apply) 
q My approach has not changed.  
q New literature on this topic 
q Discussions with my colleagues 
q First hand clinical experiences 
q Other, please specify ____________________ 
 
Q37 Any additional comments you have on this subject of trisomy 18 and cardiac 
intervention would be helpful. 
(open response text box) 
END OF SURVEY 
 
Q38 How many years since you have received your master’s in genetic counseling? 
m less than 5 years 
m 5 to 10 years 
m 11 to 15 years 
m 16 to 20 years 
m more than 20 years 
 
Q39 Please select all that apply regarding your current subspecialty in genetic 
counseling.  
m Preconception/Prenatal 
m Pediatrics/Medical Genetics 
m Other, please specify __________ 
40 
 
Q40 Please select from the choices provided your understanding of the postnatal lifespan 
of patients with non-mosaic trisomy 18: 
m No infants survive beyond one year 
m <1% survive beyond one year 
m 5-10% survive beyond one year 
m 20-25% survive beyond one year 
m I do not know 
 
Q41 How many patients with a prenatal diagnosis of trisomy 18, on average per year, 
have you participated in care for? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
m 21 or more 
m Not sure 
Q42 How many patients with a prenatal diagnosis of trisomy 18, on average per year, 
have you discussed cardiac intervention as a postnatal option? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
m 21 or more 
m Not sure 
 
The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18 
and cardiac intervention. Please remember to consider each question in regards to a 
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.  
 
Q43 Please indicate for each of the following terms below whether you agree or disagree 
with the term being used to describe patients with trisomy 18.  
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
agree 
Life-limiting m  m  m  m  m  
Vegetative m  m  m  m  m  
Incompatible with 
life m  m  m  m  m  
Lethal anomaly m  m  m  m  m  
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Q44 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion 
on the following statements below.  
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
It is appropriate to counsel families 
with an infant with trisomy 18 and 
a cardiac defect about the option of 
cardiac intervention. 
m  m  m  m  m  
It is appropriate for insurance 
companies to cover the cost of 
cardiac intervention for infants with 
trisomy 18. 
m  m  m  m  m  
Discussing the option of cardiac 
intervention for infants with a 
prenatal diagnosis of trisomy 18 is 
within my scope of practice. 
m  m  m  m  m  
 
Q45 The below reasons have been given for NOT providing cardiac surgery on infants 
with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please indicate 
your feelings toward each statement. 
 
Surgery should not be offered to infants with trisomy 18 because…  
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
Trisomy 18 is associated with 
unacceptably high mortality. m  m  m  m  m  
It is an inappropriate allocation of 
the institution's time and 
resources. 
m  m  m  m  m  
Because the perioperative 
mortality is unacceptably high in 
these infants. 
m  m  m  m  m  
The cost to society for the infants 
to undergo surgery is 
burdensome. 
m  m  m  m  m  
Surgery will not improve the 
quality of the infant's life. m  m  m  m  m  
There is insufficient research 
done examining the risks and 
benefits to the infant. 
m  m  m  m  m  
Surgery causes the infant pain and 
suffering. m  m  m  m  m  
It provides false hope for the 
family. m  m  m  m  m  
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Q46 Additional reasons you feel cardiac surgery SHOULD NOT be performed on an 
infant with trisomy 18, if any.  
(open response text box) 
 
Q47 The below reasons have been given in SUPPORT of providing cardiac surgery on 
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please 
indicate your feelings toward each statement.  
 
Surgery should be offered to infants with trisomy 18… 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q48 Additional reasons you feel cardiac surgery SHOULD be performed on an infant 
with trisomy 18, if any.  
(open response text box) 
 
Q49 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of 
this intervention is: 
 
 
 
 
 
 
 
 
 
 
 
 
Q50 Which factors have influenced your recommendations towards cardiac intervention 
for infants with trisomy 18? (check all that apply) 
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
If the parents express their desire to 
have "everything done" for their 
child. 
m  m  m  m  m  
Because the infant deserves the 
opportunity for the same 
interventions offered to other 
chromosomally normal infants with 
congenital heart defects. 
m  m  m  m  m  
Because trisomy 18 is not uniformly 
lethal. m  m  m  m  m  
Because infants with trisomy 18 can 
have an acceptable quality of life. m  m  m  m  m  
Because parent(s) alone should 
judge risk-benefit ratio for surgery. m  m  m  m  m  
 Disagree Agree 
No end benefit m  m  
Parental wishes/autonomy 
are honored m  m  
Potential for extended time 
with infant m  m  
Potential for improved 
quality of life m  m  
Other, please specify m  m  
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q Genetic counseling school training 
q First hand clinical experience 
q Discussion with colleagues 
q Parental autonomy 
q Other, please specify ____________________ 
 
Q51 Please describe your approach to discussing the option of cardiac intervention for 
infants with trisomy 18. 
m I do not discuss the option of cardiac intervention. 
m I will discuss it if brought up by the parents, but I emphasize intervention is 
discouraged. 
m I will discuss it if brought up by the parents, emphasize it may be an option, but do 
not refer to cardiac surgery. 
m I will discuss it if brought up by the parents, emphasize it may be an option, and refer 
to cardiac surgery. 
m I discuss it in all cases regardless if brought up by parents. 
m Other, please specify ____________________ 
 
Q53 Any additional comments you have on this subject of trisomy 18 and cardiac 
intervention would be helpful. 
(open response text box) 
END OF SURVEY 
 
Q54 Please select all that apply regarding your subspecialty in cardiothoracic surgery.  
m Adult cardiac surgery 
m Thoracic surgery 
m Congenital heart surgery 
m Other, please specify __________ 
 
Q55 Please select from the choices provided your understanding of the postnatal lifespan 
of patients with non-mosaic trisomy 18: 
m No infants survive beyond one year 
m <1% survive beyond one year 
m 5-10% survive beyond one year 
m 20-25% survive beyond one year 
m I do not know 
 
Q56 How many patients with a diagnosis of trisomy 18, on average per year, have you 
participated in care for? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
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m 21 or more 
m Not sure 
 
Q57 Of the patients with a diagnosis of trisomy 18 that you have participated in care for, 
on average per year, how many have undergone cardiac surgery on average per year? 
m None 
m 1-5 
m 6-10 
m 11-15 
m 16-20 
m 21 or more 
m Not sure 
 
Q58 Most patients with trisomy 18 for whom I provide consultation are: 
m Referred by their doctor 
m Self-referred 
m Other, please specify ____________________ 
 
Q59 Most patients with trisomy 18 for whom I provide consultation are: 
m Currently pregnant 
m Postnatal with a prenatal diagnosis of trisomy 18 
m Postnatal with a postnatal diagnosis of trisomy 18 
m Other, please specify ____________________ 
 
 
The remaining questions are pertaining to your attitudes and beliefs regarding trisomy 18 
and cardiac intervention. Please remember to consider each question in regards to a 
diagnosis of non-mosaic trisomy 18. Please click the arrow below to continue.  
 
Q60 Please indicate for each of the following terms below whether you agree or disagree 
with the term being used to describe patients with trisomy 18.  
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
agree 
Life-limiting m  m  m  m  m  
Vegetative m  m  m  m  m  
Incompatible with 
life m  m  m  m  m  
Lethal anomaly m  m  m  m  m  
 
Q61 On a scale of "strongly disagree" to "strongly agree," please indicate your opinion 
on the following statements below.  
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
It is appropriate to counsel families m  m  m  m  m  
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with an infant with trisomy 18 and 
a cardiac defect about the option of 
cardiac intervention. 
It is appropriate for insurance 
companies to cover the cost of 
cardiac intervention for infants with 
trisomy 18. 
m  m  m  m  m  
Discussing the option of cardiac 
intervention for infants with a 
diagnosis of trisomy 18 is within 
my scope of practice. 
m  m  m  m  m  
 
Q62 The below reasons have been given for NOT providing cardiac surgery on infants 
with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please indicate 
your feelings toward each statement. 
 
Surgery should not be offered to infants with trisomy 18 because…  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q
6
3
 
A
dditional reasons you feel cardiac surgery SHOULD NOT be performed on an infant 
with trisomy 18, if any.  
(open response text box) 
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
Trisomy 18 is associated with 
unacceptably high mortality. m  m  m  m  m  
It is an inappropriate allocation of the 
institution's time and resources. m  m  m  m  m  
The perioperative mortality is 
unacceptably high in these infants. m  m  m  m  m  
The cost to society for the infants to 
undergo surgery is burdensome. m  m  m  m  m  
Surgery will not improve the quality of 
the infant's life. m  m  m  m  m  
There is insufficient research done 
examining the risks and benefits to the 
infant. 
m  m  m  m  m  
Surgery causes the infant pain and 
suffering. m  m  m  m  m  
Surgery provides false hope for the 
family. m  m  m  m  m  
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Q64 The below reasons have been given in SUPPORT of providing cardiac surgery on 
infants with trisomy 18. On a scale of "strongly disagree" to "strongly agree," please 
indicate your feelings toward each statement. 
 
Surgery should be offered to infants with trisomy 18… 
 Strongly 
disagree 
Disagree Neutral Agree Strongly 
agree 
If the parents express their desire to 
have "everything done" for their 
child. 
m  m  m  m  m  
Because the infant deserves the 
opportunity for the same 
interventions offered to other 
chromosomally normal infants with 
congenital heart defects. 
m  m  m  m  m  
Because trisomy 18 is not uniformly 
lethal. m  m  m  m  m  
Because infants can have an 
acceptable quality of life. m  m  m  m  m  
Because parent(s) alone should 
judge risk-benefit ratio for surgery. m  m  m  m  m  
Q65 Additional reasons you feel cardiac surgery SHOULD be performed on an infant 
with trisomy 18, if any.  
(open response text box) 
  
Q66 If cardiac surgery is performed on infants with trisomy 18, I feel the end benefit of 
this intervention is: 
 Disagree Agree 
There is no end benefit m  m  
Parental wishes/autonomy are 
honored m  m  
Potential for extended time with 
infant m  m  
Potential for improved quality of 
life m  m  
Other, please specify m  m  
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Q67 How is your decision made whether or not to perform cardiac intervention for 
infants with trisomy 18? (check all that apply) 
q I never perform cardiac intervention for infants with trisomy 18. 
q I perform cardiac intervention for all infants with trisomy 18. 
q I make the decision on a case-by-case basis. 
q The decision is made at the discretion of the attending team. 
q There is a defined protocol at my institution that I abide by. 
q Other, please specify ____________________ 
 
Q68 If your approach to performing cardiac intervention to infants with trisomy 18 has 
changed over time, what has influenced this? (check all that apply) 
q My approach has not changed. 
q New literature on this topic 
q Discussions with my colleagues 
q First hand clinical experiences 
q Other, please specify ____________________ 
 
Q69 Please rank the following factors that have influenced your approach towards 
cardiac intervention for infants with trisomy 18  
(1 most influential to 4 least influential) 
______ Medical school training 
______ First hand clinical experience 
______ Discussion with colleagues 
______ Parental autonomy 
 
Q70 Have you performed cardiac surgery on an infant with trisomy 18? 
m Yes (If yes go to Q73) 
m No (If no go to Q71) 
 
Q71 Would you ever consider performing cardiac surgery on an infant with trisomy 18? 
m Yes (If yes go to Q73) 
m No (If no go to Q72) 
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Q72 Please expand on your reasoning behind never considering performing cardiac 
surgery on an infant with trisomy 18. 
(open text box)  
END OF SURVEY 
 
Q73 Please indicate which heart defects for infants with trisomy 18 you would operate 
on, in the absence of additional congenital defects:  
 
 Yes No 
Atrial Septal Defect m  m  
Ventricular Septal Defect m  m  
Patent Ductus Arteriosus m  m  
Coarctation of the Aorta m  m  
Tetralogy of Fallot m  m  
Atrioventricular Septal Defect m  m  
Hypoplastic Left Heart m  m  
Double Outlet Right Ventricle m  m  
Pulmonary Stenosis m  m  
Transposition of the Great Arteries m  m  
Other, please specify m  m  
 
Q74 Please indicate on a scale of "not at all influential" to "very influential" which of the 
following factors influence your decision when determining if an infant with trisomy 18 
is a good surgical candidate for cardiac surgery. 
 Not at all 
influential 
Somewhat 
influential 
Very 
influential 
Gender m  m  m  
Gestational age m  m  m  
Birth weight m  m  m  
Apgar scores of infant m  m  m  
Presence of additional anomalies m  m  m  
Complexity of heart defect m  m  m  
Parental request m  m  m  
Support of other healthcare team 
members m  m  m  
Recommendation of bioethics 
committee m  m  m  
Other, please specify m  m  m  
 
 
49 
Q75 In an infant with trisomy 18 with a heart defect present of mild to moderate 
complexity, the additional presence of which of the below birth defects would preclude 
an infant from surgery: 
 
 Would still  
perform surgery 
Would no 
longer  
perform 
surgery 
Cleft lip/palate m  m  
Omphalocele m  m  
Esophageal atresia with or without 
tracheoesophageal fistula  m  m  
Club foot m  m  
Congenital diaphragmatic hernia m  m  
Spina bifida m  m  
Polydactyly m  m  
 
Q76 Any additional comments on trisomy 18 and cardiac intervention would be helpful. 
(open response text box) 
END OF SURVEY 
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